Skip to content

Lung Cancer Blog

Everything about lung cancer is here.

Menu
  • Home
  • About Us
  • Lung Cancer
    • Lung Cancer News
    • Causes of Lung Cancer
    • Lung Cancer Symptoms
    • Types of Lung Cancer
    • Stages of Lung Cancer
    • Lung Cancer Treatment
    • Lung Cancer Drugs
    • Lung Cancer In Ayurveda
    • Chinese Herbs For Lung Cancer
  • Researches
  • Studies
  • Stories
  • Sitemap
  • Contact Us
Menu
Lung Cancer

Israeli Researchers Identify Relapse-free Treatment for Lung Cancer

Posted on August 28, 2023
Post Views: 270

Lung CancerThe research team of Weizmann Institute have identified biomarker that helps to prevent relapse of certain types of lung cancer. This new Israeli study could open ways to more efficient treatment for lung cancer. In this research, the team was puzzled by the fact that some patients were suffering regression with secondary gene mutations that allow tumors to develop resistance to targeted therapy drugs. They also reviewed the mutation cases in EGFR (Epidermal Growth Factor Receptor) gene which is responsible for making receptor protein. The study focused on the EGFR gene which may allow physicians to identify patients who are suitable for singular antibody-based drug. This drug could induce full remission without threat of relapse. Though smoking remains the main cause behind lung cancer, the next largest cause affecting non-smokers is characterized by mutations in a gene called EGFR.

The team has conducted the study using mice and has identified a potential biomarker identifying those patients who could benefit more long-term from a drug called cetuximab. In the trials of biological drug Erbitux, they found that it could inhibit the growth of cancerous tumors. The study was published in the Cell Reports Medicine journal.

This potential biomarker could revoutionize lung cancer treatment. The team of researchers is now preparing for the clinical trial to validate the effectivess of treatment in humans by leveraging Erbitux’s existing approval for other cancer types. Also, this could reshape the clinical practices and works towards relevant mutations that help lung cancer patients. The researchers plan to assess the drug’s effectiveness on lung cancer patients.

The information in this blog is solely for educational purposes. Consult your healthcare provider for any medical requirements or concerns. It is crucial to seek professional medical guidance for your health.

Subscribe to our newsletter or follow us on Facebook or Twitter today and never miss out an update!

Subscribe Us

Popular Articles

  • Lung Cancer Treatment in Ayurveda (6,925)
  • Lung Cancer: Symptoms and Treatment (5,277)
  • What is Non-Small-Cell Lung Cancer? (5,174)

Recent Comments

  • Lung Cancer on Asbestos and Lung Cancer – What’s The Link?
  • Scopus Asbestos on Asbestos and Lung Cancer – What’s The Link?
  • Lung Cancer on Drug: Alecensa (Alectinib) to Treat NSCLC

Recent Articles

  • Study: Physical Tests Vital in Treating Metastatic Lung Cancer October 28, 2024
  • FDA Approves Optune Luna for Metastatic NSCLC October 21, 2024
  • Research Finds Useful Information about Natural Killer Cells October 14, 2024
  • Banning Tobacco Sales Could Significantly Reduce Lung Cancer Deaths October 7, 2024
  • World Lung Day Observed on 25 September to Raise Awareness about Lung Health September 30, 2024

…

Some post may contain affiliate links, purchasing that product not going to cost extra but by your purchase Lung Cancer will get some little commission and that amount will help in surviving this website. So, please don’t hesitate to buy from these affiliate links.

Contact Us

Lung Cancer Blog provides all lung cancer related information for educational purposes. If you have any query or suggestions about our blog, please feel free to email us at lungcancersymptomsx@gmail.com.

Copyright © 2012 - 2024 Lung Cancer Blog. Wordpress by Vipasha